news

Company news IP granted Publications

2026-07-20

Risen Pharma Announces First Patient Dosed in Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease

Year:

All 2026 2025 2024 2023 2022 2021 2020

2025-05-06

Risen Pharma Announces Poster Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting

Shanghai Zhangjiang R&D Center.

Suzhou Industrial Park R&D Center.

Jiangsu Xuzhou R&D Center

Copyright 2022 Risen(Shanghai) Pharma Tech Co., Ltd. All Rights Reserved 沪ICP备16020731号-1 Design by：yushangweb